Bilal H. Lashari, Yazhini Vallatharasu, Lakshmi Kolandra, Mohsin Hamid, & Dipesh Uprety. (2018). Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug Conjugate. Adis, Springer Healthcare.
Chicago Style (17th ed.) CitationBilal H. Lashari, Yazhini Vallatharasu, Lakshmi Kolandra, Mohsin Hamid, and Dipesh Uprety. Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug Conjugate. Adis, Springer Healthcare, 2018.
MLA (9th ed.) CitationBilal H. Lashari, et al. Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug Conjugate. Adis, Springer Healthcare, 2018.
Warning: These citations may not always be 100% accurate.